Xin Su Ning—A Review of Basic and Clinical Pharmacology Integrated With Traditional Chinese Medicine Antiarrhythmic Theory
Xin Su Ning (XSN) is a patented multicomponent medicine, which was certified in 2005 by the China State Food and Drug Administration to be produced pharmaceutically and to be used clinically. The XSN capsule was developed from an effective formula composed by Prof. Shuwen Ding of Shandong University...
Saved in:
Main Authors: | Xuan Wang, Taiyi Wang, Shuwen Ding, Yu-Ling Ma |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/feb9f78c300248a6bb8fe922109414d4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of Chinese herbal medicine Wen Xin granules for the treatment of unstable angina pectoris with Yang deficiency and blood stasis syndrome: study protocol for a randomized controlled trial
by: Pan-pan Tian, et al.
Published: (2021) -
Allicin disrupts cardiac Cav1.2 channels via trafficking
by: Dan Han, et al.
Published: (2019) -
Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt/Β-catenin pathway
by: Hua Gong, et al.
Published: (2019) -
Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression
by: Yao Li, et al.
Published: (2021) -
Clinical Pharmacology: Advances and Applications
Published: (2010)